Keeps and Ro take contrasting approaches to male hair loss: Keeps as a specialist offering finasteride and minoxidil at $30 monthly with focused expertise, while Ro provides hair loss treatment ($90-$100 monthly) within a multi-category health platform covering ED, mental health, and weight loss. This evidence-based comparison examines pricing, treatment quality, medical oversight, and which platform delivers better value for men seeking to preserve their hair.
Overview: Hair Loss Specialist vs Multi-Category Telehealth Platform
Keeps and Ro represent contrasting business models in men's health telehealth. Keeps operates as a hair loss specialist with laser focus on preventing and treating male pattern baldness through finasteride and minoxidil. The platform built its brand exclusively around hair preservation, arguing concentrated expertise produces better patient outcomes and more competitive pricing than generalist competitors. Ro functions as a complete digital health company offering multiple specialized verticals: Ro Hair (hair loss), Ro Mind (mental health), Ro Pharmacy, Ro Derm (dermatology), and Ro Body (weight loss).
The fundamental strategic difference centers on specialization versus diversification. Keeps maintains that hair loss treatment requires focused attention to nuances of androgenetic alopecia, patient education about realistic expectations, and optimization of the limited evidence-based treatments available. According to
American Academy of Dermatology guidelines, only finasteride and minoxidil have substantial clinical evidence for male pattern hair loss, making deep expertise in these specific medications more valuable than broad telehealth capabilities.
Ro counters that complete platforms provide better value through economies of scale, integrated care for men treating multiple conditions, and operational sophistication built across diverse medical categories. The company went public in 2021 and serves millions of patients across various health verticals. According to
American Telemedicine Association data, multi-category platforms benefit from cross-selling opportunities and consolidated patient relationships, though they may lack the specialized depth of single-focus competitors.
Both platforms employ board-certified healthcare providers and operate under HIPAA-compliant telemedicine regulations. According to
Federation of State Medical Boards guidelines, appropriate patient-provider relationships can be established through telehealth for hair loss treatment when proper medical evaluation occurs. This comparison examines pricing competitiveness, treatment quality and innovation, patient experience, medical oversight, and which platform delivers better value for men specifically seeking hair loss treatment in 2026.
Cost Analysis: Budget Specialist vs Premium Multi-Service Platform
Keeps employs aggressive pricing designed to be the most affordable option for hair loss treatment. The essential plan combining generic finasteride 1mg daily and minoxidil 5% solution costs $90 for a 3-month supply ($30/month average). Finasteride-only treatment costs $60 for 3 months ($20/month). Minoxidil-only treatment runs $75 for 3 months ($25/month). The platform eliminated consultation fees and shipping costs, making monthly subscription costs transparent and predictable. These prices include provider oversight, prescription management, and medication delivery.
Ro prices hair loss treatment at premium levels reflecting its multi-category operational costs. Finasteride 1mg daily costs $45 monthly, while topical minoxidil runs $55 monthly. The combination treatment totals $100 monthly when purchased separately or $90 monthly through bundle pricing. Initial consultations cost $15 though subsequent refills include provider review. Over a 12-month treatment period, total costs reach approximately $1,095 at Ro ($90 monthly × 12 months + $15 initial consultation) versus $360 at Keeps ($30 monthly × 12 months), a $735 annual difference.
The pricing gap compounds dramatically over the 5+ year horizon typical for hair loss treatment. Men using combination therapy would invest approximately $5,475 at Ro versus $1,800 at Keeps over 5 years, saving $3,675 with the specialist platform—enough to cover 10 additional years of treatment at Keeps' prices. Even finasteride-only users save $1,500 over 5 years ($1,200 at Keeps versus $2,700 at Ro), representing substantial long-term value for a chronic condition requiring indefinite treatment.
However, Ro offers multi-category bundling that Keeps cannot match. Men treating erectile dysfunction alongside hair loss can consolidate: ED medications ($30-$70 monthly) plus hair loss treatment ($90 monthly) plus potentially mental health or other services within a single platform and provider relationship. According to
Trustpilot reviews averaging 4.1/5 stars for Ro, some men value the convenience of integrated care across multiple conditions despite higher per-category costs.
Both platforms accept HSA/FSA payment for prescription medications. According to
IRS Publication 502, prescription drugs including finasteride and minoxidil qualify for health savings account reimbursement when prescribed by licensed providers. Neither platform accepts insurance for hair loss treatment, standard across the telehealth industry as cosmetic hair loss is not covered by most health plans. Keeps' substantially lower pricing provides clear value advantage for men focused exclusively on hair loss, while Ro's multi-category access offers convenience for those managing several health concerns.
Medication Options: Proven Standards vs Limited Innovation
Keeps offers the two FDA-approved medications with substantial clinical evidence for male pattern hair loss. Oral finasteride 1mg daily blocks DHT (dihydrotestosterone) conversion, the primary hormone driving androgenetic alopecia. According to landmark clinical trials published in Journal of the American Academy of Dermatology02357-9/fulltext), finasteride prevents further hair loss in 83-86% of men and produces some regrowth in 60-65% over 2 years. The platform provides only the 1mg dose proven effective for hair loss, avoiding the 5mg dose used for prostate enlargement.
Topical minoxidil 5% solution at Keeps works through a different mechanism—prolonging the anagen (growth) phase of hair follicles and increasing blood flow to the scalp. Research demonstrates
minoxidil produces visible improvement in 60-70% of users after 4-12 months of twice-daily application. Keeps provides the 5% concentration proven most effective for men, delivered in a liquid solution format. The platform emphasizes that combination therapy (finasteride plus minoxidil) produces superior results to either medication alone, with some studies showing up to 90% of men maintaining or improving hair density.
Ro offers the same core medications—finasteride 1mg and minoxidil 5%—but adds topical finasteride formulations combining both medications in a single topical application. The topical finasteride approach theoretically reduces systemic exposure and potential sexual side effects while maintaining efficacy, though clinical evidence for this formulation is more limited than oral finasteride. According to
dermatology literature, topical finasteride shows promise but lacks the extensive long-term data supporting oral administration.
Treatment customization at Ro includes options for compounded formulations adding tretinoin or other adjunctive ingredients to the minoxidil solution, based on theories that these enhance absorption and efficacy. However, evidence for these combinations comes primarily from small studies rather than large randomized trials. Keeps maintains more conservative treatment protocols using only FDA-approved medications with strong clinical evidence, arguing that unproven additions increase costs without demonstrated benefit.
Neither platform can reverse advanced hair loss or grow hair in completely bald areas. Both emphasize realistic expectations: these medications preserve existing hair and may produce modest regrowth, but work best when started early in the hair loss process. According to
American Hair Loss Association data, approximately 66% of men experience some hair loss by age 35, making early intervention critical for maximum benefit from either platform.
Consultation and Ongoing Care: Streamlined Access vs Multi-Category Infrastructure
Keeps emphasizes rapid treatment access with minimal friction. New patients complete a brief online questionnaire covering hair loss pattern (using the Norwood-Hamilton scale), family history of baldness, current medications, medical conditions, and treatment goals. The intake takes approximately 5-10 minutes. Licensed physicians review submissions and approve appropriate candidates within 24 hours, with most men receiving prescription authorization quickly. The platform uses asynchronous consultations exclusively, eliminating scheduling requirements.
The Keeps approach prioritizes simplicity for a condition with straightforward treatment. Hair loss patients generally need medication access rather than extensive ongoing consultations, as treatment changes rarely occur once an effective regimen is established. Patient reviews on
Trustpilot averaging 4.5/5 stars frequently praise the easy onboarding, quick approval, and hassle-free refill process. Some users note wishing for more educational content about realistic timelines and what to expect, though most appreciate the no-nonsense medication access.
Ro implements more complete intake evaluations aligned with its multi-category medical platform. Initial questionnaires cover medical history in greater detail, potential contraindications across multiple body systems, and current medications that might interact with hair loss treatments. Physicians conduct more thorough medical screening, particularly for men planning to use finasteride who should be evaluated for prostate issues and baseline sexual function. The $15 initial consultation fee covers this more extensive review.
Follow-up care differs in structure and intensity. Keeps conducts minimal ongoing monitoring once treatment is established—patients receive quarterly prescription refills with basic check-ins about tolerance and satisfaction. The platform provides messaging access for questions but operates reactively. This lightweight approach works well for the majority of users who tolerate medications without issues and simply want continued access. Ro schedules more regular check-ins as part of its ongoing care model, particularly for men using multiple services across different verticals.
Customer service responsiveness varies based on operational focus. Keeps maintains specialized support staff focused exclusively on hair loss questions, medication issues, and subscription management. Response times typically fall under 24 hours for non-urgent questions according to reviews. Ro's larger support infrastructure handles inquiries across many service categories, potentially resulting in more variable response quality and expertise depth for hair-specific questions, though the platform benefits from greater operational resources.
Medical Oversight: Focused Safety Screening vs Complete Assessment
Keeps implements appropriate safety screening focused on finasteride and minoxidil contraindications. The platform asks about liver disease (affecting finasteride metabolism), prostate cancer history or symptoms, baseline sexual function, scalp conditions that might preclude topical minoxidil, and current medications. Men with active liver disease, prostate cancer, or severe cardiovascular conditions are excluded from treatment. According to
FDA labeling for finasteride, the medication is well-tolerated in healthy men but requires appropriate screening.
The platform provides detailed education about finasteride's potential sexual side effects, which occur in approximately 3-5% of users: decreased libido, erectile dysfunction, and reduced ejaculatory volume. According to clinical trial data, these effects are usually mild and resolve upon discontinuation, though rare cases of persistent sexual dysfunction have been reported. Keeps advises men to report any concerning symptoms and discontinue if side effects occur, following standard medical guidelines.
Ro conducts more extensive baseline assessment including prostate symptom evaluation (using IPSS questionnaire), cardiovascular risk screening, and sexual function assessment (using validated IIEF scores). This complete approach enables identification of men who might have underlying conditions requiring further evaluation before hair loss treatment. The platform can coordinate across its multiple verticals—for example, addressing erectile dysfunction concerns separately rather than automatically attributing them to finasteride.
Ongoing monitoring proves minimal at both platforms for uncomplicated cases. Neither requires routine lab testing or regular physical exams once treatment is established, aligning with standard medical practice for finasteride and minoxidil. The medications have extensive safety records with decades of use. Most side effects become apparent within the first 3-6 months, after which continued tolerance is typical. Both platforms educate about discontinuing treatment if side effects occur and seeking traditional medical evaluation for concerning symptoms.
Neither platform can definitively prove that observed hair improvement results from treatment versus natural variation, as objective measurement requires standardized photographs and hair counts rarely performed in telehealth settings. Both rely on patient-reported satisfaction and perception of improvement. This limitation affects all hair loss telehealth platforms and represents an inherent challenge in remote dermatologic treatment where objective assessment requires specialized equipment.
Hair Preservation Results: Medication Efficacy vs Platform Differences
Hair loss treatment outcomes depend almost entirely on medication efficacy rather than which platform provides the prescription, as both Keeps and Ro offer the same core medications at equivalent doses. Clinical trial data for finasteride and minoxidil comes from pharmaceutical studies independent of any telehealth platform. Men using finasteride 1mg daily can expect 83-86% probability of maintaining hair density (preventing further loss) and 60-65% chance of some regrowth over 2 years based on published research02357-9/fulltext).
Patient satisfaction at Keeps reflects both medication effectiveness and service quality. Reviews on
Trustpilot frequently describe successful hair preservation—noticing less shedding after 3-6 months, seeing regrowth in thinning areas after 6-12 months, and maintaining improvement with continued treatment. Positive reviews emphasize the affordable pricing enabling long-term adherence, straightforward refill process, and discrete packaging. Negative reviews primarily reflect unrealistic expectations (hoping for dramatic regrowth in advanced baldness) rather than service failures.
Ro patients report similar medication outcomes—clinical trial-level results when treatment works as expected. However, satisfaction comments note higher costs creating financial pressure, particularly over the 5+ year timeframes required for hair loss management. Some
Trustpilot reviews mention switching to cheaper alternatives after initial treatment with Ro, suggesting the premium pricing may reduce long-term retention for hair loss specifically despite satisfaction with medical outcomes.
Treatment adherence affects results significantly, as both finasteride and minoxidil require continuous use to maintain benefits. Studies show
discontinuation results in loss of gains within 6-12 months as DHT levels return to baseline and hair follicles revert to normal growth patterns. Platforms with lower costs potentially improve adherence by reducing financial barriers to continued treatment. The $3,675 savings over 5 years at Keeps versus Ro may improve long-term persistence through affordability.
Long-term value in hair loss treatment extends beyond initial results to sustained maintenance over decades. Men starting finasteride in their 20s or 30s may require 30-40 years of continuous treatment to preserve hair throughout their lives. At Keeps' pricing, 30 years costs $10,800 ($30/month × 360 months) versus $32,400 at Ro, a $21,600 lifetime difference. This dramatic cost disparity for medically identical treatment makes a strong case for the specialist platform unless multi-category services provide substantial additional value justifying the premium.
How We Tested Ro vs Keeps
Our Comparison Methodology
This comparison is based on complete analysis of hair loss treatment protocols, pricing structures, service models, and clinical efficacy from both platforms, supplemented by peer-reviewed dermatology research.
Clinical Evidence: Hair loss treatment recommendations reference FDA medication labels for finasteride and minoxidil, clinical trial data from Journal of the American Academy of Dermatology, and treatment guidelines from American Academy of Dermatology.
Research Foundation: We analyzed peer-reviewed studies including finasteride efficacy trials showing 90% hair maintenance over five years, minoxidil clinical research demonstrating 60% regrowth rates, and telehealth service quality from Federation of State Medical Boards.
Pricing Analysis: All pricing reflects published subscription costs as of January 2026, verified through official platform websites. HSA/FSA eligibility confirmed through IRS Publication 502.
Service Verification: Platform capabilities, provider credentials, medication sourcing, and treatment protocols were evaluated through detailed review of service offerings and Trustpilot customer experiences.
We maintain independence from both platforms and receive no compensation. Our goal is to provide evidence-based comparison to help you make informed hair loss treatment decisions.
Final Verdict: Ro vs Keeps
Choose Keeps if: You are focused exclusively on hair loss treatment and want the most affordable access to proven finasteride and minoxidil therapy. The platform delivers combination treatment for $30 monthly ($360 annually), saving $735 per year and $3,675 over 5 years compared to Ro. For a chronic condition requiring decades of treatment, these savings compound dramatically—potentially $21,600 over 30 years. The streamlined service provides appropriate medical oversight without unnecessary complexity, making it ideal for men who want simple, affordable access to medications that work identically regardless of platform. The specialist focus delivers superior value unless you need multi-category services.
Choose Ro if: You are treating multiple health conditions (hair loss plus ED, mental health, weight loss, or other concerns) and highly value managing everything through a single platform despite significantly higher per-category costs. The complete infrastructure, integrated provider relationships, and consolidated account management provide convenience for men juggling several health issues. However, you should honestly assess whether you will actively use multiple verticals—paying $90-$100 monthly for hair loss alone when medically identical treatment costs $30 at Keeps only makes sense if other Ro services provide substantial additional value justifying the premium.
The Bottom Line: For hair loss treatment specifically, Keeps delivers dramatically better value through specialized focus and affordable pricing ($30/month versus $90-$100/month at Ro). The medications are identical and work the same regardless of platform, making Ro's 3x cost premium difficult to justify unless you genuinely need and use their other health services. The $3,675 saved over 5 years at Keeps could fund an additional 10 years of treatment or be applied to other priorities. Only choose Ro for hair loss if multi-category convenience across several active treatment areas justifies paying substantially more for the same medications and similar medical outcomes.
Frequently Asked Questions
Which platform offers better pricing for hair loss treatment?
Keeps provides substantially lower costs: $30 monthly for combination finasteride and minoxidil treatment, $20 monthly for finasteride only, or $25 monthly for minoxidil only. Ro costs $90-$100 monthly for combination treatment and $45 monthly for finasteride alone. Over 5 years, Keeps saves $3,675 for combination therapy and $1,500 for finasteride monotherapy compared to Ro. Over a 30-year treatment horizon typical for men starting in their 20s or 30s, the savings approach $21,600. Unless you need Ro's other services (ED treatment, mental health, weight loss) and value consolidated multi-category care, Keeps delivers dramatically better value for hair loss specifically.
Are the hair loss medications the same quality at both platforms?
Yes, both platforms provide generic finasteride 1mg and minoxidil 5%, the FDA-approved medications with extensive clinical evidence for male pattern hair loss. These are pharmaceutical-grade generic medications that work identically regardless of which platform prescribes them. Clinical outcomes depend on the medications themselves and individual patient factors (genetics, starting point, treatment adherence) rather than which telehealth service provides the prescription. Ro offers some additional formulations like topical finasteride combinations, but the core treatments producing proven results are identical at both platforms.
Does Ro provide better medical oversight than Keeps?
Ro conducts more complete baseline assessments including prostate symptom screening, cardiovascular risk evaluation, and sexual function questionnaires, while Keeps uses focused screening specific to finasteride and minoxidil contraindications. However, for generally healthy men seeking hair loss treatment, both platforms provide medically appropriate screening and monitoring. The medications have excellent safety profiles in healthy populations with decades of use. Keeps' streamlined approach is adequate for straightforward cases, while Ro's extensive evaluation may benefit men with complex medical histories or multiple concurrent conditions. Most men do not need the additional assessment that Ro provides unless they have specific underlying health concerns.
Can I get treatment for ED or other conditions at Keeps like I can at Ro?
No, Keeps specializes exclusively in hair loss and does not offer erectile dysfunction treatment, mental health services, weight loss programs, or other health categories that Ro provides. If you want hair loss treatment alongside other men's health services, you would need multiple platforms—for example, Keeps for hair loss plus another provider for ED—or consolidate everything at Ro despite significantly higher hair loss costs. The multi-category convenience at Ro appeals to men managing several health concerns through a single platform. Men focused only on hair preservation get better value from Keeps' specialized, affordable service.
How long does it take to see results from either platform?
Results timing depends on the medications themselves rather than which platform prescribes them. Most men notice reduced hair shedding within 3-6 months of starting finasteride, as the medication stabilizes hair loss by blocking DHT. Visible regrowth typically requires 6-12 months of continuous treatment, with maximum results around 18-24 months. Minoxidil shows earlier effects in some users, with initial improvements possible at 4-6 months. Neither platform can accelerate these timelines as they reflect the biological process of hair follicle recovery. Both Keeps and Ro educate patients about realistic expectations, though some users report wanting more detailed information about the gradual nature of improvement.
Should I choose based on price or complete service?
This depends on whether you need only hair loss treatment or multiple health services. For men exclusively seeking hair preservation, Keeps delivers dramatically better value—saving $3,675 over 5 years and potentially $21,600 over 30 years for medically identical treatment. The medications work the same regardless of platform, making the 3x cost premium at Ro difficult to justify unless you actively use their other verticals (ED, mental health, weight loss). If you are treating multiple conditions and value consolidated care with one provider relationship across different health areas, Ro's premium pricing may be worthwhile. However, if hair loss is your only concern, the specialist platform provides better value by a wide margin.
Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards
